Riparian Pharmaceuticals, Inc., is a privately held biotechnology company founded to discover drug targets and therapeutics that impact endothelial dysfunction and vascular inflammation. The company's therapeutics target new vasoprotective pathways to treat both prevalent and serious rare vascular diseases at an early stage, enabling physicians to have improved patient outcomes. Riparian has raised $6M in combined investment a...
Riparian Pharmaceuticals, Inc., is a privately held biotechnology company founded to discover drug targets and therapeutics that impact endothelial dysfunction and vascular inflammation. The company's therapeutics target new vasoprotective pathways to treat both prevalent and serious rare vascular diseases at an early stage, enabling physicians to have improved patient outcomes. Riparian has raised $6M in combined investment and research services from Viva Biotech Incubator and JMCR Partners, as well as support from research foundations including the National Institutes of Health and the Massachusetts Life Science Center.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.